Welcome to the Global Solutions For Infectious Diseases Website
GSID Home Page
About Us
Our Programs
Support GSID
News & Publications
Contact Us

This content has been retired.

For more information about our programs, please click on one of the links below.




Enrollment of volunteers into the PrEPVacc Phase IIb clinical efficacy trial is underway at sites located in Uganda, Tanzania and South Africa.